🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Syngenta says Mexican remedies for ChemChina deal will not have major impact

Published 12/04/2017, 09:41
Updated 12/04/2017, 09:50
© Reuters. A Syngenta logo is pictured in their office in Singapore
SYENF
-

ZURICH (Reuters) - Swiss pesticides and seeds group Syngenta AG (S:SYNN) said Mexican regulatory conditions for approving ChemChina's [CNNCC.UL] planned $43 billion (34.44 billion pounds) takeover bid will not have a major impact on the business.

Mexico's antitrust commission COFECE approved the deal on Tuesday on condition that Syngenta divests five products, without naming them, in order to avoid risks to competition.

If the deal were carried out as originally planned by the firms, free competition would be placed at risk in certain herbicide and fungicide markets, COFECE said.

A Syngenta spokesman said the regulator's remarks were in line with the company's announcement on Monday that COFECE had approved the proposed acquisition by ChemChina.

"This approval included remedies, which are not material to our business," he said in an email.

The deal is one of several reshaping the agricultural chemicals and seeds market, even as these deals trigger fears among some farmers that bigger, more powerful suppliers could be better placed to push up prices and economise on developing new herbicides and pesticides.

Syngenta expects the deal to close in the second quarter of 2017.

© Reuters. A Syngenta logo is pictured in their office in Singapore

U.S. antitrust authorities have nodded the deal through on Tuesday on condition ChemChina divests three products, while the European Commission said planned asset sales would address its competition concerns.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.